Literature DB >> 1347296

Genetic study of a new X-linked recessive immunodeficiency syndrome.

G de Saint-Basile1, F Le Deist, M Caniglia, Y Lebranchu, C Griscelli, A Fischer.   

Abstract

Seven forms of X-linked (XL) immunodeficiency have been described (XL agammaglobulinemia, XL severe combined immunodeficiency [SCID], Wiskott-Aldrich syndrome, XL chronic granulomatous disease, XL hyper-IgM syndrome with low IgG and IgA, and XL lymphoproliferative syndrome), and properdine deficiency. Although there are (some) phenotypic variants, diagnosis is relatively simple on the basis of clinical, immunological, and genetic characteristics. We studied a family in which several males were affected by severe infections and whose pedigree suggested recessive XL inheritance of an immunodeficiency. Immunologic and genetic studies (X inactivation patterns in females and restriction fragment length polymorphism [RFLP] segregation) were performed in order to characterize the immunodeficiency. The propositus, a 5-yr-old boy, was found to have a severe and progressive T- and B-cell functional immunodeficiency characterized by defective antigen-specific responses. No lymphocyte subsets or membrane anomalies were detected and the immunodeficiency did not correspond to usual XL forms. Studies of DNA from two of the informative females, the mother and one sister revealed nonrandom X chromosome inactivation of T cells and, partially, B cells but not PMN, a pattern similar to that observed in XL SCID carriers. RFLP studies identified a haplotype segregating with the abnormal locus that may be localized in the proximal part of the long arm of the X chromosome. We thus report the characterization of a new XL immunodeficiency that may correspond either to another XL locus or to an attenuated phenotype of XL SCID.

Entities:  

Mesh:

Year:  1992        PMID: 1347296      PMCID: PMC442931          DOI: 10.1172/JCI115665

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status.

Authors:  Y Boyd; N J Fraser
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

2.  T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.

Authors:  P Brottier; L Boumsell; C Gelin; A Bernard
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome.

Authors:  G de Saint Basile; B Arveiler; N J Fraser; Y Boyd; I W Graig; G Griscelli; A Fischer
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

Review 4.  Report of the committee on the genetic constitution of the X chromosome.

Authors:  J L Mandel; H F Willard; R L Nussbaum; G Romeo; J M Puck; K E Davies
Journal:  Cytogenet Cell Genet       Date:  1989

5.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.

Authors:  W L Greer; P C Kwong; M Peacocke; P Ip; L A Rubin; K A Siminovitch
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

7.  Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.

Authors:  R W Hendriks; M De Weers; R G Mensink; M E Kraakman; I F Mollee-Versteegde; A J Veerman; L A Sandkuyl; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.

Authors:  E R Fearon; J A Winkelstein; C I Civin; D M Pardoll; B Vogelstein
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

9.  Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus.

Authors:  S P Kwan; J Terwilliger; R Parmley; G Raghu; L A Sandkuyl; J Ott; H Ochs; R Wedgwood; F Rosen
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

10.  Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.

Authors:  A Fischer; F Le Deist; A Durandy; C Griscelli
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

View more
  11 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.

Authors:  F Candotti; J J O'Shea; A Villa
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Growth hormone deficiency and combined immunodeficiency.

Authors:  M L Tang; A S Kemp
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.

Authors:  Sakari Pöysti; Firas Hamdan; Elina A Tuovinen; Kim My Le; Salla Keskitalo; Tanja Turunen; Léa Minier; Nanni Mamia; Kaarina Heiskanen; Markku Varjosalo; Vincenzo Cerullo; Juha Kere; Mikko R J Seppänen; Arno Hänninen; Juha Grönholm
Journal:  J Clin Immunol       Date:  2022-10-19       Impact factor: 8.542

6.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

Authors:  J P DiSanto; F Rieux-Laucat; A Dautry-Varsat; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

8.  Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.

Authors:  F C Schmalstieg; W J Leonard; M Noguchi; M Berg; H E Rudloff; R M Denney; S K Dave; E G Brooks; A S Goldman
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.

Authors:  Brahim Belaid; Lydia Lamara Mahammed; Aida Mohand Oussaid; Melanie Migaud; Yasmine Khadri; Jean Laurent Casanova; Anne Puel; Nafissa Ben Halla; Reda Djidjik
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

Review 10.  The diagnostic approach to monogenic very early onset inflammatory bowel disease.

Authors:  Holm H Uhlig; Tobias Schwerd; Sibylle Koletzko; Neil Shah; Jochen Kammermeier; Abdul Elkadri; Jodie Ouahed; David C Wilson; Simon P Travis; Dan Turner; Christoph Klein; Scott B Snapper; Aleixo M Muise
Journal:  Gastroenterology       Date:  2014-07-21       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.